RxDoctor Payments Data

John Beigel

Infectious Disease · Bethesda, MDNPI 1396705372

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $250 of the $250 with a category attached, or 100.0%. Every reported general payment came from a single manufacturer, Sanofi Pasteur Inc.. That places this record below the midpoint for infectious disease clinicians in MD, where the typical reported total is $209.

$250in general payments, 2019–2025

Across 1 payment — averaging $250.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi Pasteur Inc.$250
$15,040,173in research payments, 2019–2025

Across 2 payments — averaging $7,520,086 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AbbVie$15M

What the payments were for

  • Speaking & faculty fees$250100%

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Sanofi Pasteur Inc.1$250

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$250 in reported general payments places this provider in the 50th percentile of 289 infectious disease providers in Maryland.

See all infectious disease providers in Maryland →

Other infectious disease in Bethesda

See the full list for Maryland →

Where these figures come from

Is this you, or does something look wrong? →